Transcenta Holding Limited (HKG:6628)
Hong Kong
· Delayed Price · Currency is HKD 2.320
+0.230 (11.00%)
At close: Mar 10, 2026
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 1.04 billion as of March 10, 2026. Its market cap has increased by 268.86% in one year.
Market Cap
1.04B
Enterprise Value
1.22B
Revenue
10.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.32
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 1.04B, a decrease of -62.10%. That is a compound annual growth rate of -22.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 940.28M | -1.42% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brii Biosciences | 995.72M |
| Sunho Biologics | 971.95M |
| 3D Medicines | 932.46M |
| Wuhan YZY Biopharma | 1.10B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| JW (Cayman) Therapeutics Co. | 778.83M |
| Beijing Biostar Pharmaceuticals | 1.37B |
| HighTide Therapeutics | 1.37B |